Fact sheet: Manulife Healthcare

Fund information
Fund name
Manulife Healthcare AA
Fund manager company
Manulife Global Fund
Fund type
Offshore Fund
Fund manager
  • Manulife Asset Management (US) LLCsince 27/06/2008
Fund objective
The sub-fund aims to provide medium to long term capital growth for those who hold a long term investment view and who are prepared to accept significant fluctuations in the value of their investments in order to achieve long term returns. It is intended that the investments will be made on a diversified basis. The underlying investment portfolio will mainly consist of equity-related investments and equities of companies in healthcare and related industries globally and which are listed on any stock exchange. The sub-fund may invest in companies which derive a significant portion of their earnings from medical and pharmaceutical products and services. The remaining assets of the sub-fund may include bonds, deposits and other investments.
Benchmark
  • MSCI World Healthcare
Investment style
Growth
Investment method
Shares
Quick stats
1 Year return
5.7%
1 Year rank in sector
10/31
Sector
FO Equity - Pharma Health & Biotech
Yield
-
Fund size
£328m (£307m last year)
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
103
Top in this sector
Fund name1 Year
Variopartner SICAV MVGbMdtcF26.6%
BB Medtech25.8%
Fidelity Gbl Health Care23.2%
Pictet Health20.7%
Charlemagne MagnaBiphrm19.1%
...more in FO Equity - Pharma Health & Biotech

Performance snapshot

Holdings snapshot

  • USA66.4%
    UK10.3%
    Switzerland8.2%
    Ireland6.8%
    Germany4.4%
  • Pharmaceuticals48.1%
    Biotechnology/Medical23.4%
    Healthcare & Medical Products21.1%
    Health Care4.5%
    Food & Drug Retailers2.3%
  • US Equities66.4%
    UK Equities10.3%
    Swiss Equities8.2%
    Irish Equities6.8%
    German Equities4.4%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund0.8%6.9%9%5.7%32.3%98.9%
Sector3.4%10.6%13.1%2.8%42.1%134.3%
Rank within sector29 / 3219 / 3221 / 3110 / 3119 / 2422 / 24
Quartile4th3rd3rd2nd4th4th
Calendar performance
 YTD - 20162015201420132012
Fund0.2%1.3%19.2%32.3%17.6%
Sector-3.1%7.2%28.1%41%16.7%
Rank within sector8 / 3127 / 2924 / 2615 / 2414 / 24
Quartile2nd4th4th3rd3rd
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
1.89
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.65
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.59
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
11.59
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
7.72
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
-0.27
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.8
Price movement
52 week high1.94
52 week low1.64
Current bid price-
Current offer price-
Current mid price1.9
Region
1USA66.41%
2UK10.27%
3Switzerland8.2%
4Ireland6.77%
5Germany4.38%
6France2.16%
7Denmark0.98%
8Money Market0.57%
9China0.26%
Industry sector
1Pharmaceuticals48.07%
2Biotechnology/Medical23.43%
3Healthcare & Medical Products21.12%
4Health Care4.53%
5Food & Drug Retailers2.28%
6Cash & Cash Equivalents0.57%
Asset type
1US Equities66.41%
2UK Equities10.27%
3Swiss Equities8.2%
4Irish Equities6.77%
5German Equities4.38%
6French Equities2.16%
7Danish Equities0.98%
8Money Market0.57%
9Chinese Equities0.26%
Individual holdings
1JOHNSON & JOHNSON5.74%
2PFIZER INC5.57%
3BIOGEN INC4.55%
4ASTRAZENECA PLC4.44%
5ROCHE HLDG AG4.23%
6ALLERGAN PLC4.07%
7NOVARTIS AG3.96%
8ZIMMER BIOMET HLDGS INC3.93%
9AMGEN INC3.91%
Management
Fund manager group
Manulife Global Fund
Fund manager company
Manulife Global Fund
Fund type
Offshore Fund
Fund objective
The sub-fund aims to provide medium to long term capital growth for those who hold a long term investment view and who are prepared to accept significant fluctuations in the value of their investments in order to achieve long term returns. It is intended that the investments will be made on a diversified basis. The underlying investment portfolio will mainly consist of equity-related investments and equities of companies in healthcare and related industries globally and which are listed on any stock exchange. The sub-fund may invest in companies which derive a significant portion of their earnings from medical and pharmaceutical products and services. The remaining assets of the sub-fund may include bonds, deposits and other investments.
Benchmark
  • MSCI World Healthcare
Investment style
Growth
Investment method
Shares
Fund manager
NameSinceBiography
Manulife Asset Management (US) LLC27/06/2008
Compliance
Distributor Status, Reporting Fund Status, UCITS IV Compliant
Domicile
No data available.
Fund for sale in
United Kingdom, Hong Kong, Luxembourg, Offshore, Singapore
Manulife Healthcare AA
Initial charge5%
Annual charge1.75%
Min single investment£20,000
Min regular saving£1,000
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price1.8958
CurrencyUSD
Price updated28/09/2016
TypeIncome
Institutional or retail classRetail
Domicile-
Citi codeCET3
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.